-
-
-
-
-
-
-
Increasing unusual call volume: DKS CCCC IMPP VERA EMBJ GMAB DUST BCS KHC SOLZ SN ANF AI PLAB
-
-
-
-
-
-
-
Vera Therapeutics (VERA) Reiterated at Overweight by Cantor Fitzgerald on Trutakna Approval
-
-
-
-
-
-
-
Goldman Sachs on Vera Therapeutics (VERA): 'We are encouraged by today's update'
-
-
-
-
-
-
-
JPMorgan on Vera Therapeutics (VERA): 'Atacicept Well Positioned Ahead Of Competitive Updates'
-
-
-
-
-
-
-
Raymond James Reiterates Strong Buy Rating on Vera Therapeutics (VERA)
-
-
-
-
-
-
-
BofA Securities Starts Vera Therapeutics (VERA) at Buy
-
-
-
-
-
-
-
Guggenheim on Vera Therapeutics (VERA): 'we would be incremental buyers on any weakness'
-
482,687 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


